Abivax has appointed James Berger as Global Head of Marketing.
Berger is a seasoned commercial biopharmaceutical executive with more than 20 years of experience leading US and global brand strategy, product launches and life cycle management across immunology, gastroenterology, respiratory and oncology. As Global Head of Marketing at Abivax, he leads commercial strategy and brand development.
Prior to joining Abivax, Berger served as Global Franchise Head at Amgen, where he led global brand strategy and franchise growth. Before Amgen, he spent more than a decade at Takeda helping to shape the strategy, launch and growth of one of the world’s leading inflammatory bowel disease brands. Earlier in his career, he held commercial leadership roles at Amgen, Merck and Bristol Myers Squibb.
On the appointment of Berger, Michael Nesrallah, Chief Commercial Officer of Abivax, said: “We are strengthening our Commercial Leadership Team with an accomplished executive who bring deep expertise in inflammatory bowel disease.”